Important Tax Note: Portfolia has delivered all K-1s before the March 15th deadline as we do every year. As always, these documents were sent through an encrypted email to protect your information from admin@moonstonecpa.com. For any questions or issues accessing your documents, please email members@portfolia.com.
Portfolia Women’s Health Fund IV is the next evolution in its proven, category-defining investment strategy backing high-growth, high-impact innovations that are transforming the health and wellness of women across every stage of life. Building on five successful prior funds in FemTech and Active Aging, Fund IV will invest in the most promising early to growth-stage companies at the intersection of science, technology, and female biology.
Upcoming Pitch Call
May 13 | 9:30 AM PT
Every month on the 2nd Wednesday, members will have the opportunity to join the fund’s pitch call featuring 2-3 companies seeking capital. You’ll be joined by the fund partners and members. You’ll have a chance to share your questions and lend your business and consumer expertise, but if you can’t attend, you’ll always be able to listen to the recording on your member page when it’s more convenient.
Missed the last pitch call? Catch up here!
Annual Fund Performance Reports
2025 WHF4 Fund Performance Report
The 2025 financial statements are as of and for December 31, 2025. Please note all updates provided are confidential and not for distribution.
To access the file, use password:
2025WHF4Report!
Semi-Annual Company Reports
The EOY highlights 2025 as provided by the companies are linked below. Please note all updates provided are confidential and not for distribution.
To access the file, please use password: EOY25WHF4!
Women’s Health IV Portfolio Highlights
Portfolio Company Valuations
Companies In Diligence
If there are no companies in diligence, you can still volunteer and we'll contact you when a new one is being assembled.
The Companies & Leadership Team
The Portfolia FemTech III Fund is led by a world-class team of highly sophisticated and experienced investors who are leaders in their respective fields, as venture capitalists, angel investors, and innovators. They bring an expert skill-set including sourcing, diligence, deal negotiation, executive recruitment, strategy and governance. Click on photos for full bios.
The Companies
A biotech company improving women’s reproductive health through in vitro fertilization (IVF) and egg freezing.
A non-hormonal contraceptive designed to eliminate the risk of negative side effects associated with traditional hormonal contraceptives.
Manufactures sustainable, plant-based, and skin-safe personal care products designed for women managing bladder leaks and incontinence.
Developer of definitive tissue-based tests designed to diagnose and stage endometriosis.
A techbio company that builds an AI-ready data platform and decentralized research ecosystem focused on neuroimmune conditions like Long COVID, ME/CFS, and POTS.
A biotechnology company developing advanced, non-toxic, and bio-compatible “antifreeze” technology to preserve organs, tissues, and cells for regenerative medicine.
Portfolia Lead Partners
Refer A Company
The Women’s Health IV Fund will invest in 8-12 companies, from Seed to pre-IPO. We consider companies with solutions in the market, and we invest in both female- and male-led teams with a preference for gender-balanced executive teams. We only invest in companies with a U.S.-based C-Corp and have a lead investor secured. Please submit the company information below or email companies@portfolia.com with questions.
Interested in other funds?
Connect with Investor Relations at investorrelations@portfolia.com
Additional questions?
Reach out to our team at members@portfolia.com